课题基金 / 基金详情

A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study

A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study
基于 DNA 的通用季节性流感疫苗 I 期安全性和免疫原性研究
批准号:
226228
负责人:
Kobinger Gary P
金额:
$23.24万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-03-01 至 2013-03-01

项目摘要

项目成果

Kobinger Gary P的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Seasonal Influenza infection is an important medical problem. Each year many Canadians become ill with the "flu", resulting in economic loss and a substantial number of hospitalizations and deaths. The current flu vaccine is produced in chicken eggs and r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.
  • 批准号:
    443201
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.24万
  • 财政年份:
    2021
  • 负责人:
    Kobinger Gary P
  • 依托单位:
Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.
  • 批准号:
    422757
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.8万
  • 财政年份:
    2020
  • 负责人:
    Kobinger Gary P
  • 依托单位:
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
  • 批准号:
    365026
  • 项目类别:
    Operating Grants
  • 资助金额:
    $291.22万
  • 财政年份:
    2017
  • 负责人:
    Kobinger Gary P
  • 依托单位:
Development of an animal model, a protective vaccine and monoclonal antibodies against Crimean-Congo Hemorrhagic Fever Virus
  • 批准号:
    345294
  • 项目类别:
    Operating Grants
  • 资助金额:
    $102.2万
  • 财政年份:
    2016
  • 负责人:
    Kobinger Gary P
  • 依托单位:
海外基金